[go: up one dir, main page]

KR20160069857A - Compositions and methods for increasi ng telomere activity - Google Patents

Compositions and methods for increasi ng telomere activity Download PDF

Info

Publication number
KR20160069857A
KR20160069857A KR1020140175988A KR20140175988A KR20160069857A KR 20160069857 A KR20160069857 A KR 20160069857A KR 1020140175988 A KR1020140175988 A KR 1020140175988A KR 20140175988 A KR20140175988 A KR 20140175988A KR 20160069857 A KR20160069857 A KR 20160069857A
Authority
KR
South Korea
Prior art keywords
extract
berry
mixture
composition
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020140175988A
Other languages
Korean (ko)
Inventor
이경식
Original Assignee
(주)스피어테크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)스피어테크 filed Critical (주)스피어테크
Priority to KR1020140175988A priority Critical patent/KR20160069857A/en
Publication of KR20160069857A publication Critical patent/KR20160069857A/en
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/40Cornaceae (Dogwood family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638Ligustrum, e.g. Chinese privet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법에 관한 것으로서 보다 상세하게는 계면활성제를 사용하지 않아 모공의 폐쇄를 방지하면서 저분자 형태의 성분들이 피부 깊숙이 흡수되어 영양분을 공급하여 피부 노화방지, 세포분열 촉진, 피부의 면역력 증강 및 항산화 작용을 촉진하도록 한 텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법에 관한 것인바, 본 발명은 베리 추출 MF(microfarad)와 카보머, 소듐폴리아크릴레이트, 정제수, 소듐하이알루로네이트, 나이아신아미드, 아데노신, 트로메타민, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물 및 구형의 베리 그레뉼로 이루어진 것에 그 특징이 있다.The present invention relates to a composition for increasing telomeric activity and a method of preparing the composition, and more particularly, to a composition for preventing and treating skin aging The present invention relates to a composition for increasing telomeric activity that promotes cell division, promotes cell division, increases immunity of skin and promotes antioxidative action, and a method for producing the composition. The present invention relates to a method for producing a composition comprising berry-extracted MF (microfarad) It is characterized in that it is composed of acrylate, purified water, sodium hyalulonate, niacinamide, adenosine, tromethamine, hyssop extract, Earthie extract, cherry pine fruit extract and spherical berry granules.

Description

텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법{COMPOSITIONS AND METHODS FOR INCREASI NG TELOMERE ACTIVITY}Technical Field [0001] The present invention relates to a composition for increasing telomeric activity,

본 발명은 텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법에 관한 것으로서 보다 상세하게는 계면활성제를 사용하지 않아 모공의 폐쇄를 방지하면서 저분자 형태의 성분들이 피부 깊숙이 흡수되어 영양분을 공급하여 피부 노화방지, 세포분열 촉진, 피부의 면역력 증강 및 항산화 작용을 촉진하도록 한 텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법에 관한 것이다.
The present invention relates to a composition for increasing telomeric activity and a method of preparing the composition, and more particularly, to a composition for preventing and treating skin aging The present invention relates to a composition for increasing telomeric activity that promotes cell division, promotes cell division, increases immunity of skin, and promotes antioxidative action, and a method for producing the composition.

텔로미어(말단소립, telomere)는 세포시계의 역할을 담당하는 DNA의 조각들이다. 텔로미어는 그리스어의 '끝'(telos)과 '부위'(meros)의 합성어다. 세포분열이 일어나는 동안에 염색체와 DNA를 복제하는 효소는 염색체의 끝 부분으로 복제를 계속할 수 없다. Telomere (telomere) is a piece of DNA that serves as a cell clock. Telomir is a compound word of the Greek 'telos' and 'meros'. Enzymes that replicate chromosomes and DNA during cell division can not continue cloning to the end of the chromosome.

텔로미어가 없는 상태로 세포가 분열된다면 세포에 관한 정보가 들어있는 염색체의 끝 부분이 소실될 것이다. 텔로미어는 염색체의 끝 부분을 막고 있는 분해되지 않는 완충지역이라 할 수 있다. 하지만 세포가 분열되면서 텔로미어는 소실되며 텔로머레이스라는 역전사 효소에 의해서 보충된다.If the cell divides without telomeres, the end of the chromosome containing information about the cell will be lost. Telomere is an undissociated buffer zone that blocks the end of a chromosome. However, as the cells divide, the telomeres disappear and are supplemented by the telomerase enzyme telomerase.

텔로미어의 길이는 종에 따라서 매우 다양하다. 효모에서는 300~600개의 염기쌍으로 이루어져 있고, 인간의 경우 수 킬로베이스(DNA 등 핵산 연쇄의 길이 단위)로 이루어져 있다. 인간의 경우 텔로미어의 길이가 짧아짐에 따라서 세포분열을 막는 노화현상을 유발할 수 있다. The length of telomere varies greatly depending on species. In yeast, it is composed of 300 to 600 base pairs. In humans, it is composed of several kilobases (length units of nucleic acid sequences such as DNA). In humans, as the length of the telomere is shortened, it may cause aging which prevents cell division.

상기와 같은 효능을 갖는 텔로미어를 활성화시키기 위하여 종래에는 나이트 팩, 수면팩 이라는 이름으로 사용되고 있다. 이러한 종래 나이트 팩 또는 수면팩은 점도가 높아 끈적끈적한 느낌이 있으며, 계면활성제 및 오일을 사용함으로 피부에 막을 형성시켜 모공을 막음으로 피부의 호흡을 방해하고 피부 속 노폐물 배출을 억제시킴과 영양공급을 방해하여 결과적으로 푸석한 피부를 유발시키는 문제가 있다.
In order to activate the telomere having the above-mentioned effect, conventionally, it has been used under the name of night pack and sleep pack. These conventional night packs or sleeping packs have a high sticky feel due to their high viscosity. By using a surfactant and oil, they form a film on the skin to block the pores, thereby preventing skin respiration, There is a problem that it causes disturbing and consequently rash skin.

대한민국 특허공개 제2011-89887호.Korean Patent Publication No. 2011-89887. 대한민국 특허공개 제2013-137252호.Korean Patent Publication No. 2013-137252. 대한민국 특허공개 제2008-74258호.Korean Patent Publication No. 2008-74258.

이러한 종래 문제점을 감안하여 안출한 본 발명의 목적은 계면활성제와 오일 등을 사용하지 않아 피부의 막 형성을 방지하여 노폐물 배출과 영양공급 등이 용이하고 피부 흡수도가 높고 피부 호흡이 가능함으로 활발한 신진대사에 의한 항산화 작용이 우수하여 피부노화 방지 효과와 모공의 세포노화를 억제 및 피부 진정, 보습효과가 있으며, 따라서 깨끗한 피부를 유지시키는 등의 효과가 있는 텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법을 제공하는데 있다.
SUMMARY OF THE INVENTION The present invention has been made in view of the foregoing problems, and it is an object of the present invention to provide a skin care cosmetic composition which prevents film formation of a skin without using a surfactant and oil to facilitate waste discharge and nutrient supply, The present invention relates to a composition and a composition for enhancing telomeric activity which have an antioxidative effect by metabolism and have an effect of preventing skin aging, inhibiting cell senescence of pores, having a skin soothing and moisturizing effect, And a method of manufacturing the same.

상기한 본 발명의 목적은 텔로미어 활성을 증가시키기 위한 조성물에 있어서, 베리 추출 MF(microfarad)와 카보머, 소듐폴리아크릴레이트, 정제수, 소듐하이알루로네이트, 나이아신아미드, 아데노신, 트로메타민, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물 및 구형의 베리 그레뉼로 이루어진 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물에 의하여 달성된다.It is an object of the present invention to provide a composition for increasing telomeric activity, which comprises a microfarad extract of berries and a microcapsule containing carbomer, sodium polyacrylate, purified water, sodium hyaluronate, niacinamide, adenosine, tromethamine, Wherein the extract is selected from the group consisting of extracts, eyebrow extracts, extracts, eyebrows extracts, extracts of mustard seeds, extracts of pine berry, and spherical berry grenules.

상기 베리 그레뉼은 유당, 마이크로크리스탈린셀롤로우스, 토코페릴아세테이트, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물, Klucel LF ((HPC-LF)4% Soln in Berry Complex)를 혼합하여 이루어진 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물에 의하여 달성된다. The berry granules are prepared by mixing lactose, microcrystalline Lentellulose, tocopheryl acetate, Waxy extract, Earthie extract, Lycopersiconate fruit extract, and Klucel LF (HPC-LF) 4% Soln in Berry Complex. Lt; RTI ID = 0.0 > telomeric < / RTI > activity.

상기 베리 그레뉼의 크기는 0.5 ~ 1.5mm 인 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물에 의하여 달성된다. Wherein the size of the berry grenules is 0.5 to 1.5 mm.

상기 베리 추출 MF(micro fludizer)는 인삼열매 추출물, 정제수, 인삼 추출물, 송이 추출물, 녹차 추출물, 알에이치-올리고펩타이드-1, 양배추잎 추출물, 쌀겨 추출물, 토마토 추출물, 순무잎 추출물, 당근 추출물, 브로콜리 추출물, 오이 추출물, 구기자 추출물, 복분자 추출물, 아로니아 추출물, 오디 추출물, 블루베리 추출물, 오미자 추출물, 산수유 추출물, 딸기 추출물, 광나무열매 추출물, 서양산사나무열매 추출물, 영실 추출물, 무화과 추출물, 마늘 추출물, 생강 추출물로 이루어진 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물에 의하여 달성된다. The micro fludizer may be selected from the group consisting of ginseng fruit extract, purified water, ginseng extract, ginseng extract, green tea extract, aloe-oligopeptide-1, cabbage leaf extract, rice bran extract, tomato extract, Extracts, Cucumber Extracts, Gugija Extracts, Bokbunja Extracts, Aronia Extracts, Odi Extracts, Blueberry Extracts, Omiza Extracts, Corn Oil Extracts, Strawberry Extracts, Manganese Extracts, Ginger extract of the present invention.

상기 베리 추출 MF(microfludizer)의 점도가 11,000 ~ 15,000(5s/20rpm)이고 PH가 5.0 ~ 7.0인 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물에 의하여 달성된다.Wherein the viscosity of the berry-extracted microfludizer is 11,000 to 15,000 (5 s / 20 rpm) and the pH is 5.0 to 7.0.

상기 베리 추출 MF의 입자크기가 120 ~ 240㎛인 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물에 의하여 달성된다. And the particle size of the berry-extracted MF is 120 to 240 占 퐉.

본 발명의 목적을 달성하기 위한 제조방법으로는 텔로미어 활성을 증가시키기 위한 조성물의 제조방법에 있어서, 베리 추출 MF 준비공정과; 베리 그레뉼 준비공정과; 베리 추출 MF와 카보머(Carbomer), 소듐폴리아크릴레이트, 정제수, 소듐하이알루로네이트를 가온 용해하여 혼합물A를 형성시키는 혼합물A형성공정과; 베리 추출 MF와 나이아신아미드의 혼합물B과 베리 추출 MF와 아데노신의 혼합물C, 베리 추출 MF와 트로메타민의 혼합물D와 정제수, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물, 베리 추출 MF의 혼합물E의 혼합물 준비공정과; 상기 혼합물A, B, C, D,E 및 구형의 베리 그레뉼을 교반 혼합하는 혼합공정으로 이루어진 것을 텔로미어 활성을 증가시키기 위한 조성물의 제조방법.에 의하여 달성된다.In order to accomplish the object of the present invention, there is provided a method for preparing a composition for increasing telomeric activity, comprising: a berry extract MF preparation step; A berry granule preparation process; A process for forming a mixture A in which berry extract MF is mixed with a carbomer, sodium polyacrylate, purified water and sodium hylauronate to form mixture A; Berry Extract Mixture B of MF and niacinamide B and Berry Extract Mixture of MF and adenosine C, Berry Extract Mixture D of MF and tromethamine and a mixture E of purified water, waxy extract, Earthie extract, A mixture preparation process; And mixing the mixture A, B, C, D, E and spherical berry granules with stirring to obtain a composition for increasing telomeric activity.

상기 베리 그레뉼은 유당, 마이크로크리스탈린셀롤로우스를 혼합하여 가온 용해한 제1혼합물과 토코페릴아세테이트, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물을 혼합하여 형성된 제2혼합물과 Klucel LF ((HPC-LF)4% Soln in Berry Complex)를 혼합하되 제1혼합물과 제2혼합물의 혼합량에 대하여 Klucel LF ((HPC-LF)4% Soln in Berry Complex)를 40중량%를 혼합하여 이루어진 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물의 제조방법에 의하여 달성된다.
The berry granules were prepared by mixing a first mixture prepared by mixing lactic acid and microcrystalline rinse cellulose with warm mixture, a second mixture formed by mixing tocopheryl acetate, hanami extract, Earthie extract, and pine nut extract, Klucel LF ((HPC- (HPC-LF) 4% Soln in Berry Complex) was mixed with the first mixture and the second mixture in an amount of 40% by weight based on the mixing amount of the first mixture and the second mixture. Lt; RTI ID = 0.0 > telomeric < / RTI > activity.

이와 같은 본 발명은 천연재료를 사용하며 계면활성제와 오일 등을 사용하지 않아 피부의 막 형성을 방지하여 피부 호흡이 가능함으로 노폐물 배출과 저분자 형태의 성분으로 이루어진 원료 사용으로 피부 흡수도가 높아 영양공급 등이 용이하고, 활발한 신진대사에 의한 항산화 작용이 우수하여 피부노화 방지 효과와 모공의 세포노화를 억제 및 피부 진정, 보습, 미백효과가 있으며, 따라서 깨끗한 피부를 유지시키는 등의 효과가 있는 텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법을 제공하는데 있다.
The present invention uses natural materials and does not use a surfactant and oil to prevent skin film formation, thereby enabling the skin to breathe. Therefore, since the waste material is made of waste materials and a low-molecular-weight component, And has excellent antioxidative effect by active metabolism to suppress aging of skin and inhibit cell aging of pores, and has a function of cleansing, moisturizing, and whitening skin, and thus maintaining a clean skin. And a method for producing the composition.

도 1은 본 발명의 기술이 적용된 텔로미어 활성을 증가시키기 위한 조성물의 제조방법을 보여주는 공정도.
도 2는 본 발명인 액상의 베리 추출 MF가 피부흡수에 흡수되는 정도를 보여주는 그래프.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a process diagram showing a method for preparing a composition for increasing telomeric activity to which the technology of the present invention is applied. Fig.
2 is a graph showing the extent to which the liquid berry extract MF of the present invention is absorbed into the skin.

이하 본 발명의 바람직한 실시예를 첨부된 도면에 의하여 상세히 설명하면 다음과 같다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.

본 발명의 텔로미어 활성을 증가시키기 위한 조성물은 베리 추출 MF(microfarad)와 카보머(Carbomer), 소듐폴리아크릴레이트, 정제수, 소듐하이알루로네이트, 나이아신아미드, 아데노신, 트로메타민, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물 및 구형의 베리 그레뉼로 이루어진 구조이다.The composition for increasing the telomeric activity of the present invention can be obtained by extracting beryl extracted MF (microfarad) with carbomer, sodium polyacrylate, purified water, sodium hyaluronate, niacinamide, adenosine, tromethamine, A perilla extract, a perennial berry extract, and a spherical berry granule.

이때 상기 베리 그레뉼의 크기는 0.5 ~ 1.5mm 인 것을 사용하며, 상기 베리 그레뉼의 크기가 0.5mm 보다 작을 경우 마사지(스크럽) 기능이 떨어지게 되는 문제점이 있으며, 베리 그레뉼의 크기가 1.5mm 보다 클 경우 현 제형 점도에서 가라앉는 문제가 발생하여 바람직하게는 0.85 ~ 1.2mm 이다.When the size of the berry granules is less than 0.5 mm, the massage (scrub) function is deteriorated. When the size of the berry granules is less than 1.5 mm, There is a problem of sinking at the present formulation viscosity, and it is preferably 0.85 to 1.2 mm.

상기와 같은 본 발명인 텔로미어 활성을 증가시키기 위한 조성물의 제조방법은 첨부도면 도 1에 도시된 바와 같이 피부를 보호하고 항산화 효과를 갖으며 인삼의 사포닌 성분이 함유되어 있는 인삼열매 추출물, 정제수, 항산화 작용이 우수하여 피부노화방지 효과 및 몸속의 세포노화를 막아 주는 사포닌이 다량 함유된 인삼추출물, 피부를 보호하고, 안티 에이징 효과를 갖는 송이 추출물, DNA 보강 성분이 있는 녹차 추출물, 마늘 추출물, 생강추출물 및 피부보호, 피부진정, 신진대사 촉진에 효능이 있는 알에이치-올리고펩타이드-1, 양배추잎 추출물, 쌀겨 추출물, 토마토 추출물, 순무잎 추출물, 당근 추출물, 브로콜리 추출물, 오이 추출물, 구기자 추출물, 복분자 추출물, 아로니아 추출물, 오디 추출물, 블루베리 추출물, 오미자 추출물, 산수유 추출물, 딸기 추출물, 광나무열매 추출물, 서양산사나무열매 추출물, 영실 추출물, 무화과 추출물 등이 혼합되어 이루어진 베리 추출 MF(microfludizer)를 베리 추출 MF 준비공정(S100)에 의해 제조한다.As shown in FIG. 1, the method of manufacturing a composition for increasing telomeric activity according to the present invention is characterized in that it comprises a ginseng fruit extract, purified water, antioxidant activity, antioxidant activity, Ginseng extract, which protects against aging of skin and protects against cell senescence, ginseng extract which contains a large amount of saponin to protect against skin aging, ginseng extract with anti-aging effect, green tea extract with DNA-reinforcing component, garlic extract, ginger extract Leaf extract, Rice bran extract, Tomato extract, Seaweed extract, Carrot extract, Broccoli extract, Cucumber extract, Gugija extract, Bokbunja extract, Glycyrrhiza uralensis extract, Aronia extract, Audi extract, Blueberry extract, Omija extract, Corn oil extract, (MF) preparation step (S100) of a berry extract MF (microfludizer), which is a mixture of a strawberry extract, a mushroom extract, a western scarlet raspberry extract, a royal rosemary extract and a fig extract.

상기 베리 추출 MF의 제조는 탱크에 각 저온 추출된 원료를 혼합한 후 회전속도 60rpm으로 40~80℃의 온도 범위에서 10분간 혼합하며, 이때 상기 베리 추출 MF(microfarad)의 점도는 11,000 ~ 15,000(5s/20rpm)이고 PH가 5.0 ~ 7.0, 입자크기가 120 ~ 240㎛인 것을 사용한다.The viscosity of the berry-extracted MF (microfarad) is in the range of 11,000 to 15,000 (at a temperature of 40 to 80 ° C for 10 minutes) at a rotation speed of 60 rpm after mixing the raw materials extracted at low temperatures into the tank. 5s / 20 rpm), a PH of 5.0 to 7.0, and a particle size of 120 to 240 mu m.

상기 베리 추출 MF(microfludizer)의 점도가 11,000(5s/20rpm) 이하이면 생산된 그레뉼이 가라앉는 문제가 있고, 점도가 15,000(5s/20rpm) 이상이면 베리 추출물 MF와 그레뉼 혼합시 그레뉼이 깨지는 문제가 있다. When the viscosity of the berry extract MF is less than 11,000 (5s / 20 rpm), there is a problem that the produced granules sink. When the viscosity is 15,000 (5s / 20 rpm) or more, the berry extract MF and the granule There is a problem of cracking.

한편 베리 추출 MF의 입자크기를 120 ~ 240㎛인 것을 사용한다. 그 이유는 첨부도면 도 2에 도시된 바와 같이 피부에 용이하게 흡수될 수 있는 입자크기이기 때문이다.On the other hand, the particle size of berry-extracted MF is 120 to 240 탆. This is because the particle size can be easily absorbed into the skin as shown in FIG. 2 attached hereto.

상기 베리 추출 MF는 항산화제 역할을 하는 안토시아닌 성분이 높아 세포분열을 촉진시키며 노화방지에 탁월하고 항염 효과 및 피부진정, 보호 효과와 다양한 비타민을 함유하고 있어 뛰어난 보습효과 및 피지 컨트롤 효과가 높다.The berry extract MF has a high anthocyanin component which acts as an antioxidant, promotes cell division, and is excellent in anti-aging, anti-inflammatory effect, skin soothing, protection effect and various vitamins.

또한 사포닌 함량이 풍부하여 항산화 작용이 우수하고 몸속의 세포노화를 막아 피부 노화방지 및 호흡하는 피부에 스스로 침투하여 뛰어나 영향성분을 공급하게 된다. 더불어 천연복합비타민(A, B1, B2, B6, C, D, E, K, P)등이 과다 함유되어 있어 피부의 면역증강 및 진정 보습력을 부여하게 된다.In addition, it is rich in saponin content, so it has excellent antioxidant effect, prevents aging of cells in the body, penetrates into the skin to prevent skin aging and breathes, and exerts excellent influences. In addition, it contains a lot of natural complex vitamins (A, B1, B2, B6, C, D, E, K, P) and gives skin's immunity enhancement and soothing moisture.

상기와 같이 베리 추출 MF의 준비가 완료되면 베리 추출 MF(microfarad)와 점증제인 카보머(Carbomer), 피부 컨디셔닝제인 소듐폴리아크릴레이트를 용매로 사용되는 정제수에 가온 용해시켜 혼합물A를 형성시킨다(혼합물A 형성공정 S200 참조). 이때 용해조건은 회전속도 60rpm 가열온도는 80℃ 가열시간 30분이다.As described above, when the preparation of the berry-extracted MF is completed, the berry-extracted MF (microfarad), the thickening agent Carbomer, and the skin conditioning agent sodium polyacrylate are dissolved in purified water used as a solvent to form a mixture A A forming process S200). At this time, the melting condition is a rotational speed of 60 rpm, a heating temperature is 80 DEG C, and a heating time is 30 minutes.

상기에서와 같이 베리 추출 MF의 준비가 완료되면 베리 추출 MF와 나이아신아미드의 혼합물B과 베리 추출 MF와 아데노신의 혼합물C, 베리 추출 MF와 트로메타민의 혼합물D와 정제수, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물, 베리 추출 MF의 혼합물E를 각각 제조하는 혼합물 준비공정(S400)을 수행한다.As described above, when the preparation of berry extract MF is completed, a mixture B of berry extract MF and niacinamide, a mixture C of berry extract MF and adenosine, a mixture D of berry extract MF and tromethamine, purified water, A mixture preparation step (S400) of preparing a mixture E of berry extract MF and berry extract MF is carried out.

한편 베리 그레뉼 준비공정(S300)도 동시에 수행할 수 있다. 상기에서와 같이 베리 추출 MF의 준비가 완료되면 베리 추출 MF와 카보머(Carbomer), 소듐폴리아크릴레이트, 정제수, 소듐하이알루로네이트를 가온 용해하여 혼합물A를 형성시키는 혼합물A형성공정(S200)을 수행한다.Meanwhile, the berry granule preparation step (S300) can be performed at the same time. As described above, when the preparation of the berry-extracting MF is completed, a process A (S200) of forming a mixture A in which the berry-extracted MF and the carbomer, sodium polyacrylate, purified water and sodium hyaluronate are dissolved by heating to form the mixture A, .

상기 혼합물A, B, C, D, E 및 구형의 베리 그레뉼의 준비가 완료되면 이를 탱크에 넣고 교반 혼합하는 혼합공정(S500)을 수행하여 조성물을 제조한다.When the preparation of the mixture A, B, C, D, E and spherical berry granules is completed, a mixing step (S500) of placing the mixture in a tank and stirring and mixing is performed to prepare a composition.

상기 방법에 의해 제조된 본 발명인 조성물의 조성비는 혼합물A 74중량%, 혼합물B 7.00중량%, 혼합물C 2.04중량%, 혼합물D 2.40중량%, 혼합물E 13.60중량% 및 베리 그레뉼1.10중량%를 혼합한다. The composition ratio of the composition of the present invention prepared by the above method is such that mixture A of 74% by weight, mixture B of 7.00% by weight, mixture C of 2.04% by weight, mixture D of 2.40% by weight, mixture E of 13.60% by weight and berry granules of 1.10% do.

상기 혼합물들을 구성하는 개별 원료의 배합비를 살펴보면 혼합물A는 베리 추출 MF 66.39중량%, 카보머 0.40중량%, 피부 컨디셔닝제인 소듐폴리아크릴레이트 0.10중량%, 정제수 6.93중량%이다.The blend ratio of the individual raw materials constituting the mixtures is 66.39% by weight of berry extract MF, 0.40% by weight of carbomer, 0.10% by weight of sodium polyacrylate as skin conditioning agent, and 6.93% by weight of purified water.

한편 각 혼합물의 구성에 있어서, 혼합물B은 베리 추출 MF 5.00중량%와 나이아신아미드 2.00중량%, 혼합물C는 베리 추출 MF 2.00중량%, 아데노신0.04중량%, 혼합물D는 베리 추출 MF 2.00중량%, 트로메타민 0.40중량%, 혼합물E는 정제수 0.35중량%, 할미꽃 추출물 0.05중량%, 어스니어 추출물 0.05중량%, 초피나무열매 추출물 13.10중량%이다.On the other hand, in the composition of each mixture, mixture B contained 5.00% by weight of berry extract MF and 2.00% by weight of niacinamide, mixture C was 2.00% by weight of berry extract MF, 0.04% by weight of adenosine, 2.00% 0.40% by weight of methamine, 0.35% by weight of purified water, 0.05% by weight of water extract, 0.05% by weight of earth extract, and 13.10%

상기 베리 그레뉼은 유당 74.40중량%, 마이크로크리스탈린셀롤로우스 25.00중량%를 혼합하여 가온 용해한 제1혼합물과 토코페릴아세테이트 1.0중량%, 정제수 0.35중량%, 할미꽃추출물 0.05중량%, 어스니어추출물 0.05중량%, 초피나무열매추출물 0.05중량%을 혼합하여 형성된 제2혼합물을 교반하여 베이스를 형성시킨 후 냉각하고 Klucel LF ((HPC-LF)4% Soln in Berry Complex)를 혼합하되 제1혼합물과 제2혼합물의 전체 혼합량에 대하여 Klucel LF ((HPC-LF)4% Soln in Berry Complex)를 40중량%를 혼합하여 제조한다.The berry grenules consisted of 1.0% by weight of tocopheryl acetate, 0.35% by weight of purified water, 0.05% by weight of horseradish extract, 0.05% by weight of Asnuria extract, a mixture of 74.40% by weight of lactose and 25.00% by weight of microcrystalline cellulose, (HPC-LF) 4% Soln in Berry Complex) was mixed with the first mixture and the second mixture was mixed with 0.05% by weight of the first mixture and the second mixture, And 40 wt% of Klucel LF ((HPC-LF) 4% Soln in Berry Complex) was added to the total mixture amount of the mixture.

상기 혼합물을 일정한 크기를 갖는 구형의 형태를 갖는 베리 그레뉼을 제조하는 방법으로는 유당 74.40중량%, 마이크로크리스탈린셀롤로우스 25.00중량%를 혼합하여 80℃에서 30분 동안 60rpm으로 교반하여 혼합한다. 상기 제1혼합물이 제조되면 토코페릴아세테이트 1.0중량%, 정제수 0.35중량%, 할미꽃추출물 0.05중량%, 어스니어추출물 0.05중량%, 초피나무열매추출물 0.05중량%을 혼합하여 형성된 제2혼합물을 탱크에 투입하여 80℃에서 30분 동안 60rpm으로 교반하여 혼합한다. As a method for producing a berry granule having a spherical shape having a predetermined size, 74.40% by weight of lactose and 25.00% by weight of microcrystalline cellulose were mixed and stirred at 80 rpm for 30 minutes at 60 rpm. When the first mixture was prepared, a second mixture formed by mixing 1.0% by weight of tocopheryl acetate, 0.35% by weight of purified water, 0.05% by weight of horseradish extract, 0.05% by weight of Earther extract and 0.05% And stirred at 80 rpm for 30 minutes at 60 rpm.

상기 구형의 형태를 갖는 베리 그레뉼을 제조하는 방법을 좀더 구체적으로 살펴보면 우선 식물성 보습제인 유당(Lactose)과 스크럽제인 마이크로크리스탈린셀롤로우스(Microcrystalline cellulose)에 활성 성분과 바인더 성분을 갖는 하이드록시프로피셀롤로우스(Hydroxypropylcellulose)를 혼합하고 믹싱기를 사용하여 작은 덩어리(시드)를 얻는다.In more detail, the method for producing the berry granules having the spherical morphology will be described in detail. First, Lactose, a vegetable moisturizer, and microcrystalline cellulose, a scrubbing agent, are mixed with hydroxypropylcellulose having an active ingredient and a binder component. Hydroxypropylcellulose is mixed and a small lump (seed) is obtained using a mixing machine.

상기 작은 덩어리들을 1.5mm 매쉬(거름망)를 사용하여 1차 분류 후, 0.5mm 매쉬 (거름망)을 사용하여 2차 분류하여, 0.5~1.5mm 의 균일한 작은 덩어리(시드) 들은 얻는다. The small lumps are first classified using a 1.5 mm mesh (sieve), and then classified using a 0.5 mm mesh (sieve) to obtain uniform small lumps (seeds) of 0.5 to 1.5 mm.

최종적으로 얻은 작은 덩어리(시드)를 그레뉼 레이터(비드형성기)를 사용하여 비드화(구형성)한 후, 상기 매쉬(거름망)를 사용하여 크기를 선별하는 방법으로 0.5~1.5mm 비드를 얻은 후 선별된 비드를 50℃에서 약 18시간 건조시켜 건조 감량 20%이하 그레뉼을 얻는다. A bead (0.5 mm to 1.5 mm bead) is obtained by beading (forming a sphere) using a granulator (bead former) and then selecting the size using the above mesh The selected beads are dried at 50 ° C for about 18 hours to obtain grains having a dry weight loss of 20% or less.

이와 같은 본 발명은 천연재료를 사용하며 계면활성제와 오일 등을 사용하지 않아 피부의 막 형성을 방지하여 피부 호흡이 가능함으로 노폐물 배출과 저분자 형태의 성분으로 이루어진 원료 사용으로 피부 흡수도가 높아 영양공급 등이 용이하고, 활발한 신진대사에 의한 항산화 작용이 우수하여 피부노화 방지 효과와 모공의 세포노화를 억제 및 피부 진정, 보습, 미백효과가 있으며, 따라서 깨끗한 피부를 유지시키는 등의 효과가 있는 유용한 발명이다.
The present invention uses natural materials and does not use a surfactant and oil to prevent skin film formation, thereby enabling the skin to breathe. Therefore, since the waste material is made of waste materials and a low-molecular-weight component, It is easy to use, has excellent antioxidative effect by active metabolism, and has a useful effect of preventing aging of skin and inhibiting cell aging of pores, maintaining skin clean, moisturizing and whitening effect, to be.

S100 : 베리 추출 MF 준비공정 S200 : 혼합물A 형성공정
S300 : 베리 그레뉼 준비공정 S400 : 혼합물 준비공정
S500 : 혼합공정
S100: Berry extraction MF preparation process S200: Mixture A formation process
S300: Berry granulation preparing process S400: Mix preparation process
S500: Mixing process

Claims (8)

텔로미어 활성을 증가시키기 위한 조성물에 있어서,
베리 추출 MF(microfarad)와 카보머(Carbomer), 소듐폴리아크릴레이트, 정제수, 소듐하이알루로네이트, 나이아신아미드, 아데노신, 트로메타민, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물 및 구형의 베리 그레뉼로 이루어진 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물.
A composition for increasing telomeric activity,
Berry Extract MF (microfarad) and Carbomer, sodium polyacrylate, purified water, sodium hyaluronate, niacinamide, adenosine, tromethamine, hiruma extract, earth extract, ≪ / RTI > wherein the composition is made of granules.
제1항에 있어서,
상기 베리 그레뉼은 유당, 마이크로크리스탈린셀롤로우스, 토코페릴아세테이트, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물, Klucel LF ((HPC-LF)4% Soln in Berry Complex)를 혼합하여 이루어진 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물.
The method according to claim 1,
The berry granules are prepared by mixing lactose, microcrystalline Lentellulose, tocopheryl acetate, Waxy extract, Earthie extract, Lycopersiconate fruit extract, and Klucel LF (HPC-LF) 4% Soln in Berry Complex. ≪ / RTI > to increase telomer activity.
제1항에 있어서,
상기 베리 그레뉼의 크기는 0.5 ~ 1.5mm인 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물.
The method according to claim 1,
Wherein the size of the berry grenules is 0.5 to 1.5 mm.
제1항에 있어서,
상기 베리 추출 MF(microfarad)는 인삼열매추출물, 정제수, 송이 추출물, 녹차 추출물, 알에이치-올리고펩타이드-1, 양배추잎 추출물, 쌀겨 추출물, 토마토 추출물, 순무잎 추출물, 당근 추출물, 브로콜리 추출물, 오이 추출물, 구기자 추출물, 복분자 추출물, 아로니아 추출물, 오디 추출물, 블루베리 추출물, 오미자 추출물, 산수유 추출물, 딸기 추출물, 광나무열매 추출물, 서양산사나무열매 추출물, 영실 추출물, 무화과 추출물, 마늘 추출물, 생강 추출물로 이루어진 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물.
The method according to claim 1,
The microfarad extracts of the berry extracts were obtained from ginseng fruit extract, purified water, pine nut extract, green tea extract, aloe-oligopeptide-1, cabbage leaf extract, rice bran extract, tomato extract, nettle leaf extract, carrot extract, broccoli extract, , Gugija Extract, Bokbunja Extract, Aronia Extract, Odie Extract, Blueberry Extract, Omija Extract, Corn Oil Extract, Strawberry Extract, Manganese Extract, Western Hawthorn Extract, Youngsil Extract, Fig Extract, Garlic Extract and Ginger Extract Lt; RTI ID = 0.0 > telomeric < / RTI > activity.
제1항에 있어서,
상기 베리 추출 MF의 점도가 11,000 ~ 15,000(5s/20rpm)이고 PH가 5.0 ~ 7.0인 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물.
The method according to claim 1,
Wherein the berry-extracted MF has a viscosity of 11,000 to 15,000 (5 s / 20 rpm) and a pH of 5.0 to 7.0.
제1항에 있어서,
베리 추출 MF의 입자크기가 120 ~ 240㎛인 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물.
The method according to claim 1,
Wherein the particle size of berry-extracted MF is 120 to 240 탆.
텔로미어 활성을 증가시키기 위한 조성물의 제조방법에 있어서,
베리 추출 MF 준비공정과;
베리 그레뉼 준비공정과;
베리 추출 MF와 카보머, 소듐폴리아크릴레이트, 정제수, 소듐하이알루로네이트를 가온 용해하여 혼합물A를 형성시키는 혼합물A형성공정과;
베리 추출 MF와 나이아신아미드의 혼합물B과 베리 추출 MF와 아데노신의 혼합물C, 베리 추출 MF와 트로메타민의 혼합물D와 정제수, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물, 베리 추출 MF의 혼합물E의 혼합물 준비공정
상기 혼합물 A, B, C, D, E 및 구형의 베리 그레뉼을 교반 혼합하는 혼합공정으로 이루어진 것을 텔로미어 활성을 증가시키기 위한 조성물의 제조방법.
A method for preparing a composition for increasing telomeric activity,
Berry extraction MF preparation process;
A berry granule preparation process;
A process for forming a mixture A, wherein the berry extract MF is dissolved by heating the carbomer, sodium polyacrylate, purified water and sodium hylauronate to form a mixture A;
Berry Extract Mixture B of MF and niacinamide B and Berry Extract Mixture of MF and adenosine C, Berry Extract Mixture D of MF and tromethamine and a mixture E of purified water, waxy extract, Earthie extract, Mix preparation process
And mixing the mixture A, B, C, D, E and spherical berry grenules with stirring to obtain a composition for increasing telomeric activity.
제7항에 있어서,
상기 베리 그레뉼은 유당, 마이크로크리스탈린셀롤로우스를 혼합하여 가온 용해한 제1혼합물과 토코페릴아세테이트, 할미꽃 추출물, 어스니어 추출물, 초피나무열매 추출물을 혼합하여 형성된 제2혼합물과 Klucel LF ((HPC-LF)4% Soln in Berry Complex)를 혼합하되 제1혼합물과 제2혼합물의 혼합량에 대하여 Klucel LF ((HPC-LF)4% Soln in Berry Complex)를 40중량%를 혼합하여 이루어진 것을 특징으로 하는 텔로미어 활성을 증가시키기 위한 조성물의 제조방법.
8. The method of claim 7,
The berry granules were prepared by mixing a first mixture prepared by mixing lactic acid and microcrystalline rinse cellulose with warm mixture, a second mixture formed by mixing tocopheryl acetate, hanami extract, Earthie extract, and pine nut extract, Klucel LF ((HPC- (HPC-LF) 4% Soln in Berry Complex) was mixed with the first mixture and the second mixture in an amount of 40% by weight based on the mixing amount of the first mixture and the second mixture. A method for preparing a composition for increasing telomeric activity.
KR1020140175988A 2014-12-09 2014-12-09 Compositions and methods for increasi ng telomere activity Ceased KR20160069857A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140175988A KR20160069857A (en) 2014-12-09 2014-12-09 Compositions and methods for increasi ng telomere activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140175988A KR20160069857A (en) 2014-12-09 2014-12-09 Compositions and methods for increasi ng telomere activity

Publications (1)

Publication Number Publication Date
KR20160069857A true KR20160069857A (en) 2016-06-17

Family

ID=56343900

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140175988A Ceased KR20160069857A (en) 2014-12-09 2014-12-09 Compositions and methods for increasi ng telomere activity

Country Status (1)

Country Link
KR (1) KR20160069857A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115669834A (en) * 2022-11-09 2023-02-03 上海亓迹化妆品有限公司 Antioxidant and anti-aging composition, beauty drink and preparation method thereof
CN117379360A (en) * 2023-02-20 2024-01-12 广东人参果农业科技有限公司 A kind of production technology of ginseng fruit facial mask

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080074258A (en) 2007-02-08 2008-08-13 김성영 Herbal Sleeping Pack containing 16 kinds of herbal extracts and its manufacturing method
KR20110089887A (en) 2003-06-23 2011-08-09 제론 코포레이션 Compositions and Methods for Increasing Telomerase Activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110089887A (en) 2003-06-23 2011-08-09 제론 코포레이션 Compositions and Methods for Increasing Telomerase Activity
KR20130137252A (en) 2003-06-23 2013-12-16 제론 코포레이션 Compositions and methods for increasing telomerase activity
KR20080074258A (en) 2007-02-08 2008-08-13 김성영 Herbal Sleeping Pack containing 16 kinds of herbal extracts and its manufacturing method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115669834A (en) * 2022-11-09 2023-02-03 上海亓迹化妆品有限公司 Antioxidant and anti-aging composition, beauty drink and preparation method thereof
CN117379360A (en) * 2023-02-20 2024-01-12 广东人参果农业科技有限公司 A kind of production technology of ginseng fruit facial mask

Similar Documents

Publication Publication Date Title
CN106666722B (en) A kind of spiral algae sheet and preparation method thereof
CN107837208B (en) Preparation method of telomerase composition and application of telomerase composition in anti-aging and anti-retrogrowth cosmetics
CN104082821A (en) Manufacturing method for haw crystal
KR20160069857A (en) Compositions and methods for increasi ng telomere activity
CN103169108A (en) Direct tablet compressing method for spirulina powder
CN102487969A (en) Multifunctional suspension type seed coating agent and preparation method thereof
HK1205452A1 (en) Medicament containing taraxacum plant root extract for treatment or prevention of cancer, and method for preparing same
KR101814170B1 (en) Food Using Stachys Sieboldii and Manufacturing Method thereof
KR101239630B1 (en) Soap and method for manufacturing thereof
CN106069322A (en) A kind of high-quality Fructus actinidiae chinensis planting matrix
CN105285451A (en) Compound feed additive for laying hens and preparation method of compound feed additive
CN104473164A (en) Processing method of rose and ginkgo seed health crystal
CN103704400A (en) Edible Xinyang Maojian tea powder and preparation method thereof
CN107149629A (en) A kind of matrimony vine fat capsule with anti-oxidation efficacy and preparation method thereof
CN105055492A (en) Preparation for tonifying Yang, strengthening body and improving immunity and preparation method of preparation
CN105687031A (en) Total-effect multifunctional moisturizing cream and preparation method thereof
KR101223746B1 (en) Mixed Tea Using Leaf, Root Bark and Fruit of Mulberry Tree
CN103609777A (en) Natural green tea cream and preparation method thereof
CN104130061A (en) Blueberry fruit tree organic fertilizer capable of inhibiting weed growth and preparation method thereof
CN107468562A (en) A kind of deep layer cleaning moisturizing mud mask and preparation method thereof
CN105581180A (en) Hair blackening and feature beautifying instant black sesame seed paste
CN106667878A (en) Moisturizing and whitening mask liquid containing herba dendrobii polysaccharides
CN104286047A (en) Agent used for controlling cucumber powdery mildew, and preparation method thereof
CN104738618A (en) Pure maca tablet granulated and tableted by use of dry method without accessories and preparation method of pure maca tablet
KR20200089370A (en) Kochujang comprising sprout ginseng powder as an active ingredient and method for preparing thereof

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20141209

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160803

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20170327

Patent event code: PE09021S02D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20170907

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170327

Comment text: Final Notice of Reason for Refusal

Patent event code: PE06011S02I

Patent event date: 20160803

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I